M. de Wilde

First name
M.
Last name
de Wilde
Tan, E. H., Robinson, D. E., Jödicke, A. M., Mosseveld, M. ., Bødkergaard, K. ., Reyes, C. ., … Sanchez-Santos, M. T. (2023). Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporos Int. http://doi.org/10.1007/s00198-023-06837-0
Voss, E. A., Shoaibi, A. ., Lai, Y. H., Blacketer, C. ., Alshammari, T. ., Makadia, R. ., … Ryan, P. B. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
Lane, J. C. E., Weaver, J. ., Kostka, K. ., Duarte-Salles, T. ., Abrahao, M. T. F., Alghoul, H. ., … Prieto-Alhambra, D. . (2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771
Lane, J. C. E., Weaver, J. ., Kostka, K. ., Duarte-Salles, T. ., Abrahao, M. T. F., Alghoul, H. ., … Prieto-Alhambra, D. . (2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9